Cyclacel製藥 CYCC 深 滬
等待開盤 08-26 09:30:00 美东时间
7.55
-0.440
-5.51%
華盛通- 最 高7.83
- 今 開7.83
- 成交量 3.37万股
- 最 低 7.30
- 昨 收 7.99
- 總市值 1195.92万
- 52周最高 597.60
- 市盈率 靜 --
- 換手率 2.12%
- 52周最低 3.0801
- 委 比 89.27%
- 總股本 158.40万
- 歷史最高 7067520.00
- 量 比 0.38
- 振 幅 6.63%
- 歷史最低 7.30
- 每 手 1
- 風險率 1.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cyclacel Pharmaceuticals declares $0.15 dividend
Cyclacel Pharmaceuticals (NASDAQ:CYCC) declares $0.15/share quarterly dividend, in line with previous. Forward yield 6.75% Payable May 1; for shareholders of record April 29; ex-div April 29. See CYCC...
08-14 13:25
Cyclacel Pharmaceuticals Implements Reverse Stock Split in July
An announcement from Cyclacel Pharmaceuticals ( ($CYCC) ) is now available. Cyc...
08-14 05:55
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
Cyclacel Pharmaceuticals公布了2025年第二季度财报，现金及等价物增至430万美元。公司宣布两次季度现金股息，每股0.15美元，并与马来西亚FITTERS达成19.99%股权交换协议，后者将成为其全资子公司。同时，公司实施了1:15反向股票分割以符合纳斯达克要求。研发费用下降40%，至100万美元，净亏损收窄至130万美元。
08-13 20:05
Cyclacel Pharmaceuticals Stock Up 34.6% In Massive After-Hours Rally
After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 34.56% to $13.20 in after-hours trading.
08-05 14:53
Reported Earlier, Cyclacel Announces New Findings Supporting Use Of Plogosertib In Biliary Tract Cancer Patients With High BUBR1 Expression
Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis
08-05 14:42
Cycle Pharmaceuticals Enters Exclusive U.S. Deal With Handa To Launch FDA-Approved Leukemia Drug PHYRAGO In September 2025
Cycle Pharmaceuticals (Cycle Pharma) has entered into an exclusive U.S. commercialization agreement with Handa Therapeutics, LLC (Handa), for PHYRAGO, an FDA approved drug for treating two types of leukemia, Philadelphia
07-21 21:28
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Shares of Block, Inc. (NYSE:XYZ) rose sharply in pre-market trading ahead of th...
07-21 18:04
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 90.1% to $2.3 during...
07-19 01:06
Cyclacel Addresses Stock Volatility Amid Exchange Amendment
The latest update is out from Cyclacel Pharmaceuticals ( ($CYCC) ). On July 16,...
07-16 21:30
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
Cyclacel Pharmaceuticals, Inc. commented on recent stock price volatility, stating no material developments or changes to its operations or financial condition were responsible for the fluctuations on July 15, 2025. The company emphasized no adverse changes to its business strategy or prospects beyond what has been publicly disclosed, including an amendment to the Exchange Agreement with FITTERS Diversified Berhad announced on July 7, 2025. Cycla...
07-16 13:00
